コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the setting of spotty skin pigmentation and endocrinopathy.
2 ted with spotty pigmentation of the skin and endocrinopathy.
3 nent neurological deficits, vision loss, and endocrinopathy.
4 activity and the presence of retinopathy and endocrinopathy.
5 , but at higher incidences in particular for endocrinopathies.
6 onicus, intrauterine growth retardation, and endocrinopathies.
7 isfolding of exportable proteins can trigger endocrinopathies.
8 histiocytosis, opportunistic infections, and endocrinopathies.
9 ated by bilateral involvement and associated endocrinopathies.
10 zed by medullary thyroid carcinoma and other endocrinopathies.
11 ascular disease, secondary malignancies, and endocrinopathies.
12 sis and optimal management of opioid-induced endocrinopathies.
13 n EEC-enriched proteases are associated with endocrinopathies.
14 nts and a high rate (57%) of immune-mediated endocrinopathies.
15 , 54 [17.0%] patients experienced persistent endocrinopathies, 48 (15.1%) experienced nonendocrinopat
18 age, gender, and the occurrence of systemic endocrinopathies also influence sulfotransferase gene ex
20 us illnesses and more common for poisonings, endocrinopathies and for children with race/ethnicity ca
22 pes, which also increase risk for autoimmune endocrinopathies and other autoimmune disorders, encode
24 gery, the medical treatment specifically for endocrinopathies, and finally, radiation treatments incl
26 on irAEs including rash, colitis, hepatitis, endocrinopathies, and pneumonitis have been established.
32 nteropathy, skin disease, pulmonary disease, endocrinopathy, arthritis, autoimmune hepatitis, neurolo
33 only treatment that can prevent or cure the endocrinopathies associated with multiple endocrine neop
35 imary hyperparathyroidism (PHPT) is a common endocrinopathy characterized by hypercalcemia and elevat
36 the most commonly encountered perioperative endocrinopathy, continues to increase dramatically in pr
37 diac amyloidosis, autonomic dysfunction, and endocrinopathy contribute to cardiac complications in AD
38 ome characterized by autoimmune enteropathy, endocrinopathy, dermatitis, and other autoimmune phenome
39 disease, organomegaly (or lymphadenopathy), endocrinopathy, edema (peripheral edema, ascites, or eff
42 sprue in asymptomatic patients, and multiple endocrinopathies in individuals with type 2 disease may
46 ullary thyroid carcinoma (MTC), the dominant endocrinopathy in patients with these hereditary syndrom
48 nic kidney disease (CKD), colorectal cancer, endocrinopathies (including type 2 diabetes mellitus [T2
51 lity can result from testicular dysfunction, endocrinopathies, lifestyle factors (such as tobacco and
52 ed to refer to polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) remains poo
53 ts disability in Polyneuropathy Organomegaly Endocrinopathy Monoclonal-protein and Skin Changes (POEM
54 lyradiculoneuropathy, organomegaly, multiple endocrinopathies, monoclonal protein, skin changes) is a
57 aly) or POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder and skin
58 HHV8-MCD), and polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin ch
59 ally including coexisting Castleman disease, endocrinopathy, monoclonal plasma cell neoplasm, and ski
60 mmon features: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes) is
61 aracterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes.
64 premature onset of chronic diseases, such as endocrinopathies, osteoporosis, cardiac dysfunction, sub
65 s undergoing CSI were more likely to develop endocrinopathies (P < .0001) and to require special educ
66 c findings of MAS including hyperfunctioning endocrinopathies, polyostotic fibrous dysplasia, and caf
67 nclude infections, toxins, cancer treatment, endocrinopathies, pregnancy, tachyarrhythmias, and immun
68 al plasma cell disorder (PCD), organomegaly, endocrinopathy, skin changes, edema, sclerotic bone lesi
70 e granulomatous disease such as sarcoidosis, endocrinopathies such as thyroid disease, immobilization
71 nimal operative morbidity and eradication of endocrinopathy support the minimally invasive approach f
72 neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome (IPEX; MIM 304930) is the geneti
74 ommended with grade 4 toxicities, except for endocrinopathies that have been controlled by hormone re
75 primary adrenal insufficiency (and no other endocrinopathies) were admitted at the in-patient clinic